The global Veterinary Pharmaceutical Drugs Market was valued at USD 57.24 billion in 2025 and is projected to grow from USD 61.54 billion in 2026 to USD 109.75 billion by 2034, registering a CAGR of 7.5% during the forecast period (2026–2034).

The market is witnessing substantial growth owing to increasing awareness regarding animal health, rising incidences of infectious and chronic diseases among livestock and companion animals, and the growing availability of advanced veterinary treatments. Increasing pet adoption and expanding veterinary healthcare infrastructure are further supporting market expansion worldwide.

Key Highlights

• North America dominated the global veterinary pharmaceutical drugs market.
• Asia-Pacific is expected to be the fastest-growing regional market during the forecast period.
• By animal type, the Production Animal segment accounted for the largest market share.
• The Companion Animal segment is anticipated to witness the fastest growth over the forecast period.
• By product type, Pharmaceuticals represented the largest segment.
• The Biologics segment is expected to record the fastest growth during the forecast period.

Market Size

Market Dynamics

Market Driver

The growing prevalence of infectious and non-infectious diseases among livestock and companion animals is driving the demand for veterinary pharmaceutical drugs. Rising awareness regarding animal welfare and increasing expenditure on veterinary healthcare have encouraged pet owners and livestock producers to adopt advanced medicines and preventive healthcare solutions. In addition, growing pet humanization trends and increasing consumption of animal-derived food products are contributing to market growth.

Another important factor supporting market expansion is the increasing number of veterinary clinics and hospitals worldwide. Advancements in veterinary diagnostics, improved access to healthcare services, and rising approvals for novel veterinary drugs are enabling effective disease management and boosting pharmaceutical adoption across animal healthcare applications.

Market Restraint

Stringent regulatory requirements associated with veterinary drug approvals and the high cost of research and development remain major challenges for manufacturers. Compliance with varying regulatory frameworks across countries often prolongs product commercialization and increases operational expenses.

Furthermore, concerns regarding antimicrobial resistance and restrictions on the use of certain drugs in food-producing animals are limiting market growth. Limited veterinary healthcare access in underdeveloped regions also poses challenges for industry expansion.

Market Opportunity

Increasing investments in biologics and vaccine development are creating lucrative opportunities for market participants. Growing emphasis on preventive healthcare and rising adoption of advanced treatment solutions are encouraging innovation across the veterinary pharmaceutical sector.

Moreover, rapid growth in emerging economies, increasing livestock populations, expanding companion animal ownership, and favorable government initiatives aimed at improving animal welfare are expected to provide significant growth opportunities throughout the forecast period.

Top Market Players

• Elanco
• Merck Animal Health
• Vetoquinol S.A.
• Boehringer Ingelheim GmbH
• Ceva Santé Animale
• Zoetis
• Kindred Biosciences Inc.
• Nutreco N.V.
• Virbac
• Biogenesis Bago
• Neogen Corporation
• Phibro Animal Health
• Hester Biosciences
• Indian Immunologicals Ltd.

Market Segmentation

By Animal Type

• Production
• Companion

By Product Type

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

By Region

• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• Latin America

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/veterinary-pharmaceutical-drugs-market

The report provides comprehensive insights into market trends, growth drivers, opportunities, competitive landscape, regional outlook, and strategic developments shaping the future of the veterinary pharmaceutical drugs industry.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.

Contact Us

Email: sales@straitsresearch.com

U.S.: +1 646 905 0080

U.K.: +44 203 695 0070